A new class of imaging agents that can target specific organs and even specific molecules is shepherding in a new level of disease detection and metabolic mapping. The ability of this new generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care.
Targetable and activatable imaging agents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. From amyloid plaques and soft tissue tumors to myocardial perfusion and therapeutic nuclear medicine, the ability of noninvasive diagnostics to detect pathologies, monitor therapeutic outcomes, guide interventional procedures and play an active role in disease therapies is positioned to increase dramatically.
Targeted and activatable imaging agents offer a unique capability to generate unambiguous images by exploiting specific molecular targets, pathways or cellular processes. This new wave of imaging agents signals a paradigm shift in which consumables take on a higher level of importance in supplier business models.
These findings are contained in a new and comprehensive report. Molecular Imaging Agents: Technology, Targets and Commercial Prospects. The report contains in-depth analysis of the growing importance of targeted imaging agents across a range of imaging modalities, a trend that will have a profound influence on the future of diagnostic imaging.
Greystone Associates (greystoneassociates.org) is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.